15 Independence Blvd. in Warren — Courtesy: Newmark
By Joshua Burd
A life sciences company and an insurance firm have joined the tenant roster of a 107,000-square-foot office building in Warren, in a set of newly completed deals by Newmark.
In the larger transaction, Tevogen Bio has taken 6,708 square feet at 15 Independence Blvd., which sits just north of Interstate 78. The clinical stage biotechnology company, which specializes in developing cell and gene therapies in oncology and viral infections, will use the space as a new corporate office, allowing it to access other biopharma service providers and the specialized talent pool in the area.
“Our new corporate hub at 15 Independence Boulevard in Warren, located in New Jersey’s biotech corridor, will serve as the company’s central location for corporate operations and was selected after thorough countrywide market research,” said Dr. Ryan Saadi, Tevogen’s CEO. “The facility represents an important operational next step to best strategically support the diversification and expansion of Tevogen’s portfolio of T cell immunotherapies.”
In the second deal, Transverse Insurance Group committed to 5,763 square feet at 15 Independence.
“We are pleased to welcome both Tevogen Bio and Transverse Insurance to the building,” said Dan Reider, a managing director with Newmark. “These new transactions are a testament to ownership’s hands-on approach, and the care with which they manage the property.”
Reider represented Mitsui Sumitomo Insurance Co. of America, which owns the building and occupies most of the space, and is marketing available units of 11,445 and 5,452 square feet. David Jaffe of Century 21 Burke Realty and Cushman & Wakefield’s Ryan DePaul and Ed Duenas represented the respective tenants.